Therapeutic area

Musculoskeletal and connective tissue disorders – page 42

865 clinical trials
357 recruiting
328 conditions
28 countries

Clinical trials in Musculoskeletal and connective tissue disorders

865 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

865 clinical trials

Psoriatic arthropathy

Not recruiting

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Investigational

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Sonelokimab
Sponsor:MoonLake Immunotherapeutics AG

Contact Research Centre

Myasthenia gravis

Not recruiting

Study on Long-Term Safety and Effectiveness of Zilucoplan in Adults with Generalized Myasthenia Gravis

Registered drugNo placebo

Study on Long-Term Safety and Effectiveness of Zilucoplan in Adults with Generalized Myasthenia Gravis

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:ZILUCOPLAN
Sponsor:UCB Biopharma

Contact Research Centre

Osteoporosis

Not recruiting

Study Comparing MAB-22 and Denosumab for Treating Osteoporosis in Postmenopausal Women

Registered drugNo placebo

Study Comparing MAB-22 and Denosumab for Treating Osteoporosis in Postmenopausal Women

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Denosumab
Sponsor:Xentria Inc.

Contact Research Centre

Systemic scleroderma

Not recruiting

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

InvestigationalNo placebo

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Fipaxalparant
Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Study of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)

Registered drug

Study of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Obexelimab
Sponsor:Zenas Biopharma (USA) LLC

Contact Research Centre

Study on the Effectiveness and Safety of LY06006 and Denosumab for Postmenopausal Women with Osteoporosis

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of LY06006 and Denosumab for Postmenopausal Women with Osteoporosis

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Denosumab
Sponsor:Shandong Boan Biotechnology Co. Ltd.

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Study on the Effects of AP1189 and Methotrexate for Patients with Early Rheumatoid Arthritis and Active Inflammation

Registered drug

Study on the Effects of AP1189 and Methotrexate for Patients with Early Rheumatoid Arthritis and Active Inflammation

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Methotrexate
Sponsor:Synact Pharma ApS

Contact Research Centre

Dermatomyositis

Not recruiting

Study on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis

Registered drug

Study on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Human Normal Immunoglobulin
Sponsor:CSL Behring LLC

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Study on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo

Study on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Abatacept
Sponsor:Dr Reddy's Laboratories Limited

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Investigational

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Guselkumab
Sponsor:Janssen Cilag International

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

InvestigationalNo placebo

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Anifrolumab
Sponsor:AstraZeneca AB

Contact Research Centre

Systemic scleroderma

Not recruiting

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Investigational

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Fipaxalparant
Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Contact Research Centre

Substances studied in this area

The therapies tested most often in Musculoskeletal and connective tissue disorders trials.

Sodium Chloride47 clinical trials Paracetamol32 clinical trials Tocilizumab29 clinical trials Methotrexate25 clinical trials Adalimumab24 clinical trials Rituximab23 clinical trials Cyclophosphamide20 clinical trials Etanercept20 clinical trials Baricitinib17 clinical trials

Musculoskeletal and connective tissue disorders – page 42

Conditions in this area

Clinical trials in Musculoskeletal and connective tissue disorders

865 clinical trials

Psoriatic arthropathy

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Myasthenia gravis

Study on Long-Term Safety and Effectiveness of Zilucoplan in Adults with Generalized Myasthenia Gravis

Osteoporosis

Study Comparing MAB-22 and Denosumab for Treating Osteoporosis in Postmenopausal Women

Systemic scleroderma

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Systemic lupus erythematosus

Study of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)

Study on the Effectiveness and Safety of LY06006 and Denosumab for Postmenopausal Women with Osteoporosis

Study on the Effectiveness and Safety of LY06006 and Denosumab for Postmenopausal Women with Osteoporosis

Rheumatoid arthritis

Study on the Effects of AP1189 and Methotrexate for Patients with Early Rheumatoid Arthritis and Active Inflammation

Dermatomyositis

Study on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis

Rheumatoid arthritis

Study on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis

Psoriatic arthropathy

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Systemic lupus erythematosus

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

Systemic scleroderma

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.